Central Securities Clearing System Plc is set to host a webinar as part of industry-wide engagement ahead of Nigeria’s transition to the T+2 Settlement cycle. In a statement on Wednesday, CSCS said ...

Cancer stem cells, characterized with self-renewal, differentiation, heterogeneity, plasticity and tumorigenicity, are regulated by intrinsic factors such as signaling pathways, transcription factors, ...

Central Securities Clearing System (CSCS) Plc has achieved a total revenue growth of 37 per cent to N26.1 billion for the year ended December 31, 2024. In line with CSCS’s commitment to delivering ...

The cancer stem cell (CSC) concept posits that a subpopulation of neoplastic cells with stem-cell properties — particularly the capacity to self-renew and give rise to various more differentiated cell ...

This month's special issue of Laboratory Investigation focuses on cancer stem cells (CSCs) and pluripotent/multipotent stem cells. These two types of stem cells ...

The Central Securities Clearing System Plc (CSCS) will hold a webinar as part of industry-wide engagement ahead of Nigeria’s transition to the T+2 Settlement cycle. The webinar titled ‘Advancing ...

The Central Securities Clearing System Plc (CSCS) has announced the launch of *7270#, its Unstructured Supplementary Service Data (USSD) code service, set to go live on May 8th, 2025. According to a ...

The revenue of Central Securities Clearing System Plc has risen by 37 per cent to N26.1bn in the 2024 financial year compared to N19bn in the previous year. This was indicated in a statement on its ...

CSCS, a subsidiary of the Nigerian Stock Exchange (NSE), listed a total of 5.0 billion ordinary shares of N1 each under the financial industry sector. CSCS is the 16th securities and eighth financial ...